Efficacy and safety of apremilast in patients with moderate-to-severe genital psoriasis: Results from DISCREET, a phase 3 randomized, double-blind, placebo-controlled trial-Reference-Cited by-同舟云学术

Efficacy and safety of apremilast in patients with moderate-to-severe genital psoriasis: Results from DISCREET, a phase 3 randomized, double-blind, placebo-controlled trial

Published:2023-10 Issue: Volume: Page:
ISSN:0190-9622
Container-title:Journal of the American Academy of Dermatology
language:en
Short-container-title:Journal of the American Academy of Dermatology

Author:

Merola Joseph F.,Parish Lawrence Charles,Guenther Lyn,Lynde Charles,Lacour Jean-Philippe,Staubach Petra,Cheng Sue,Paris Maria,Picard Hernan,Deignan Cynthia,Jardon Shauna,Chen Mindy,Papp Kim A.

Funder

Amgen

Publisher

Elsevier BV

Subject

Dermatology

Reference28 articles.

1. Validity study for the stigmatization experience in atopic dermatitis and psoriatic patients;Schmid-Ott;Acta Derm Venereol,1999

2. Genital psoriasis is associated with significant impairment in quality of life and sexual functioning;Ryan;J Am Acad Dermatol,2015

3. Patients' perspectives on the impact of genital psoriasis: a qualitative study;Cather;Dermatol Ther (Heidelb),2017

4. Patients' experience of psoriasis in the genital area;Meeuwis;Dermatology,2012

5. Genital psoriasis: a systematic literature review on this hidden skin disease;Meeuwis;Acta Derm Venereol,2011

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Effectiveness of deucravacitinib for genital, nail and scalp lesions in patients with psoriasis: a 24-week real-world study;Clinical and Experimental Dermatology;2024-08-03

2. Shedding Light on Shadows: A Cross‐Sectional Analysis of Genital Psoriasis and Its Effects on Thai Individuals;Dermatology Research and Practice;2024-01

3. Phosphodiesterase-4 Inhibition in the Management of Psoriasis;Pharmaceutics;2023-12-22